Barinthus Biotherapeutics (BRNS) Minority Interest (2020 - 2026)
Barinthus Biotherapeutics' (BRNS) quarterly Minority Interest came in at $79000.0 in Q1 2026, down 20.2% YoY from $99000.0 in Q1 2025, and down 5.95% on a QoQ basis from $84000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Minority Interest (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 7 years of Minority Interest data on file, last reported at $79000.0 in Q1 2026.
- Quarterly Minority Interest fell 20.2% year-over-year to $79000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79000.0 (down 20.2% YoY) and the FY2025 annual result came in at $84000.0, down 20.75% from the prior year.
- Minority Interest slipped to $79000.0 in Q1 2026, from $84000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $400000.0 in Q1 2022 to a low of $79000.0 in Q1 2026.
- A 5-year average of $200764.7 and a median of $183000.0 in 2024 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2022 — Minority Interest sank 99.77% — and 2024, when it fell 18.54%.
- Tracing BRNS's Minority Interest over 5 years: stood at $305000.0 in 2022, then sank by 30.82% to $211000.0 in 2023, then tumbled by 49.76% to $106000.0 in 2024, then slipped by 20.75% to $84000.0 in 2025, then slipped by 5.95% to $79000.0 in 2026.
- The last three Minority Interest figures came in at $79000.0 (Q1 2026), $84000.0 (Q4 2025), and $96000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Barinthus Biotherapeutics | 25.29 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 211,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | 253,000.00 |
| Mar 31, 2023 | 268,000.00 |
| Dec 31, 2022 | 305,000.00 |
| Sep 30, 2022 | 315,000.00 |
| Jun 30, 2022 | 366,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 437,000.00 |
| Sep 30, 2021 | 493,000.00 |